Firm News: Drugs & Devices: Page 14

Low T Treatments Linked to Cardiac Incidents

Medical studies have linked using popular Low T testosterone supplements to an increased risk of heart attack, stroke and other cardiac events. Weitz & Luxenberg is currently investigating the danger these products pose. If you or a loved one has experienced a heart attack, stroke or other heart problem after using Low T products, please…

FDA Probes Dangers of Metal Hips

The FDA has announced plans to commission a study of the corrosion that occurs in certain models of metal hip implants, saying more data is needed to safeguard patients. The devices in question —prosthetic hip joints that have modular junctions which provide more options at implantation but pose risks for excess mechanical motion causing fretting and…

Accutane $9 Million Verdict

A former Accutane user was awarded $9 million by a New Jersey jury against Hoffmann La-Roche Inc. and Roche Laboratories, subsidiaries of Roche Holding AG (ROG). The pharmaceutical companies are based in Nutley, N.J. The plaintiff, one of four in a combined trial, took Accutane for acne treatment from 1997-1998 when she was a teenager. …

Shoulder Pain Pump Risk

Weitz & Luxenberg P.C. would like to inform patients of a debilitating condition, postarthroscopic glenohumeral chondrolysis (PAGCL), which results in the permanent degeneration of shoulder cartilage. This devastating and painful process has been linked to a post-surgical treatment for shoulder pain that has been performed across the country. Pain pumps are used to manage post-operative…

$13.5 Million in Vioxx Trial

Weitz & Luxenberg client John McDarby, 77, and his wife were rewarded a $4.5 million dollar verdict and $9 million in punitive damages from a New Jersey jury in one of the first Vioxx trial cases against Merck. ”The verdict is a victory for the 100,000 Americans who had heart attacks from Vioxx,” said lawyer Robert Gordon.…

Get the Help You Need Today

Free Case Review